Balcinrenone in combination with dapagliflozin compared with dapagliflozin alone in patients with chronic kidney disease and albuminuria: a randomised, active-controlled double-blind, phase 2b clinical trial.

Heerspink HJL, Cardona JF, Jolly S, Pergola PE, de Sousa-Amorim E, Eriksson AL, Fredholm M, Gasparyan SB, Guzman NJ, Hartleib-Geschwindner J, Jiang Y, Leonsson-Zachrisson M, Mark PB, MIRO-CKD study investigators

Open source

DOI
10.1016/s0140-6736(25)02014-8
Published
2025 Nov 22
Container
Lancet (London, England)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-25-02014-8,
  title = {Balcinrenone in combination with dapagliflozin compared with dapagliflozin alone in patients with chronic kidney disease and albuminuria: a randomised, active-controlled double-blind, phase 2b clinical trial.},
  author = {Heerspink HJL and Cardona JF and Jolly S and Pergola PE and de Sousa-Amorim E and Eriksson AL and Fredholm M and Gasparyan SB and Guzman NJ and Hartleib-Geschwindner J and Jiang Y and Leonsson-Zachrisson M and Mark PB and MIRO-CKD study investigators},
  year = {2025},
  journal = {Lancet (London, England)},
  doi = {10.1016/s0140-6736(25)02014-8},
  url = {https://doi.org/10.1016/s0140-6736(25)02014-8}
}

RIS

TY  - JOUR
TI  - Balcinrenone in combination with dapagliflozin compared with dapagliflozin alone in patients with chronic kidney disease and albuminuria: a randomised, active-controlled double-blind, phase 2b clinical trial.
AU  - Heerspink HJL
AU  - Cardona JF
AU  - Jolly S
AU  - Pergola PE
AU  - de Sousa-Amorim E
AU  - Eriksson AL
AU  - Fredholm M
AU  - Gasparyan SB
AU  - Guzman NJ
AU  - Hartleib-Geschwindner J
AU  - Jiang Y
AU  - Leonsson-Zachrisson M
AU  - Mark PB
AU  - MIRO-CKD study investigators
PY  - 2025
JO  - Lancet (London, England)
DO  - 10.1016/s0140-6736(25)02014-8
UR  - https://doi.org/10.1016/s0140-6736(25)02014-8
ER  - 

APA

HJL, H., JF, C., S, J., PE, P., E, D. S., AL, E., M, F., SB, G., NJ, G., J, H., Y, J., M, L., PB, M., & investigators, M. S. (2025). Balcinrenone in combination with dapagliflozin compared with dapagliflozin alone in patients with chronic kidney disease and albuminuria: a randomised, active-controlled double-blind, phase 2b clinical trial.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(25)02014-8

Source records